長新冠

Inflammaging, immunosenescence, and cardiovascular aging: insights into long COVID implications

by admin | 6月 26, 2024 | 臨床表現、傳播、流行病、病毒、病理生理學, 長新冠, 科學抗疫, 自衞抗疫, 病毒、病理生理學

對不起，此内容只適用於English。By Ludmila Müller et al. Source Frontiers Aging leads to physiological changes, including inflammaging—a chronic low-grade...

Short- and long-term neuropsychiatric outcomes in long COVID in South Korea and Japan

by admin | 6月 25, 2024 | 長新冠, 快遞點評

對不起，此内容只適用於English。By Sunyoung Kim et al. Source Nature Abstract We investigated whether SARS-CoV-2 infection is associated with short- and...

We Won’t Solve Long COVID Until We Decide What It Is

by admin | 6月 18, 2024 | 長新冠

對不起，此内容只適用於English。By F. Perry Wilson Source Medscape This transcript has been edited for clarity. Welcome to Impact Factor, your weekly dose of...

Profiles of objective and subjective cognitive function in Post‐COVID Syndrome, COVID‐19 recovered, and COVID‐19 naïve individuals

by admin | 6月 11, 2024 | 長新冠

對不起，此内容只適用於English。By A. R. Bland et al. Source Nature Post-COVID Syndrome has emerged as a significant public health concern worldwide with...

National Academies Issue New Broad Definition of Long COVID

by admin | 6月 11, 2024 | 長新冠

對不起，此内容只適用於English。By Miriam E. Tucker Source Medscape A new broadly inclusive definition of long COVID from the National Academies of Sciences,...

Long-Term Patient Symptoms and Quality of Life in Adults After COVID-19: A Real Life Study

by admin | 6月 11, 2024 | 西醫臨床科硏實證, 長新冠, 科學抗疫

對不起，此内容只適用於English。By Oscar Perez et al. Source sciencedirect Abstract Objective To characterize long-term patient-reported symptoms and quality of...

The impact of COVID-19 on “biological aging”

by admin | 6月 10, 2024 | 長新冠

對不起，此内容只適用於English。By Fathima Humaira Amanullah et al. Source Frontiers The global impact of the SARS-CoV-2 pandemic has been unprecedented, posing...

Paxlovid Fails First Test in Long COVID

by admin | 6月 7, 2024 | 長新冠

對不起，此内容只適用於English。By Kristina Fiore Source Medpagetoday A 15-day course of the antiviral nirmatrelvir-ritonavir (Paxlovid) didn't improve symptoms...